April 2014

In this edition of Clinical Forum, we asked Cardiology Review editorial board members and an invited guest to comment on the controversial new cholesterol guidelines and risk calculator issued by the American Heart Association (AHA) and American College of Cardiology (ACC) in November 2013.

More than 13,000 physicians and cardiovascular team members attended the ACC 2014 meeting in Washington, DC, to focus on the prevention, diagnosis, and treatment of cardiovascular disease.

Editor-in-Chief Debabrata Mukherjee, MD, MS, FACC, previews this issue's illuminating content.

A recent study published in BMJ Open suggests that taking nonsteroidal anti-inflammatory medications raises the risk of atrial fibrillation.

The updated valvular heart disease guidelines issued by the American Heart Association and American College of Cardiology now incorporate transcatheter aortic valve implantation, which is now recommended for patients who are not candidates for surgery and would be expected to survive longer than 1 year after intervention.

An examination of the cost-effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation patients.

The authors of this review believe the efficacy of a drug is important, but it is not the full story.

Exploring the benefits of routine use of noninvasive cardiac testing for patients with suspected coronary ischemia.

Researchers investigated the effects of sleepiness, sleep hygiene, sleep disorders, and driving risk among highway drivers in France.

An exploration into the elusive and controversial topic of renal artery stenosis and its optimal therapy.

A review of the relationship between body mass index, metabolic syndrome, and cardiovascular disease and all-cause mortality.

Clinicians have been able to review these guidelines in detail and also take a closer look at how they relate to their patients and practice, the resulting answers are enlightening